Medical Care
Global Oncolytic Virus Manufacturing and Development Services Market Research Report 2026
- Feb 24, 26
- ID: 706611
- Pages: 114
- Figures: 120
- Views: 2
This report delivers a comprehensive overview of the global Oncolytic Virus Manufacturing and Development Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oncolytic Virus Manufacturing and Development Services. The Oncolytic Virus Manufacturing and Development Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Oncolytic Virus Manufacturing and Development Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Oncolytic Virus Manufacturing and Development Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Recipharm (Vibalogics)
IDT Biologika
FUJIFILM Diosynth Biotechnologies
Exothera
Lonza
Creative Biolabs
Takara Bio
Libentech
ABL
Nabios
Halix
Obio Technology
Porton Advanced
WuXi ATU
Genevoyager
Segment by Type
Oncolytic Herpes Simplex Virus
Oncolytic Adenovirus
Oncolytic Vaccinia Virus
Others
Segment by Application
R&D
Biopharmaceutical Manufacturers
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Oncolytic Virus Manufacturing and Development Services companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Oncolytic Virus Manufacturing and Development Services market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Oncolytic Virus Manufacturing and Development Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Recipharm (Vibalogics)
IDT Biologika
FUJIFILM Diosynth Biotechnologies
Exothera
Lonza
Creative Biolabs
Takara Bio
Libentech
ABL
Nabios
Halix
Obio Technology
Porton Advanced
WuXi ATU
Genevoyager
Segment by Type
Oncolytic Herpes Simplex Virus
Oncolytic Adenovirus
Oncolytic Vaccinia Virus
Others
Segment by Application
R&D
Biopharmaceutical Manufacturers
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Oncolytic Virus Manufacturing and Development Services companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Oncolytic Herpes Simplex Virus
1.2.3 Oncolytic Adenovirus
1.2.4 Oncolytic Vaccinia Virus
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oncolytic Virus Manufacturing and Development Services Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 R&D
1.3.3 Biopharmaceutical Manufacturers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Manufacturing and Development Services Market Perspective (2021–2032)
2.2 Global Oncolytic Virus Manufacturing and Development Services Growth Trends by Region
2.2.1 Global Oncolytic Virus Manufacturing and Development Services Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Oncolytic Virus Manufacturing and Development Services Historic Market Size by Region (2021–2026)
2.2.3 Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Region (2027–2032)
2.3 Oncolytic Virus Manufacturing and Development Services Market Dynamics
2.3.1 Oncolytic Virus Manufacturing and Development Services Industry Trends
2.3.2 Oncolytic Virus Manufacturing and Development Services Market Drivers
2.3.3 Oncolytic Virus Manufacturing and Development Services Market Challenges
2.3.4 Oncolytic Virus Manufacturing and Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Manufacturing and Development Services Players by Revenue
3.1.1 Global Top Oncolytic Virus Manufacturing and Development Services Players by Revenue (2021–2026)
3.1.2 Global Oncolytic Virus Manufacturing and Development Services Revenue Market Share by Players (2021–2026)
3.2 Global Top Oncolytic Virus Manufacturing and Development Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Oncolytic Virus Manufacturing and Development Services Revenue
3.4 Global Oncolytic Virus Manufacturing and Development Services Market Concentration Ratio
3.4.1 Global Oncolytic Virus Manufacturing and Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Manufacturing and Development Services Revenue in 2025
3.5 Global Key Players of Oncolytic Virus Manufacturing and Development Services Head Offices and Areas Served
3.6 Global Key Players of Oncolytic Virus Manufacturing and Development Services, Products and Applications
3.7 Global Key Players of Oncolytic Virus Manufacturing and Development Services, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Oncolytic Virus Manufacturing and Development Services Breakdown Data by Type
4.1 Global Oncolytic Virus Manufacturing and Development Services Historic Market Size by Type (2021–2026)
4.2 Global Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Type (2027–2032)
5 Oncolytic Virus Manufacturing and Development Services Breakdown Data by Application
5.1 Global Oncolytic Virus Manufacturing and Development Services Historic Market Size by Application (2021–2026)
5.2 Global Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Oncolytic Virus Manufacturing and Development Services Market Size (2021–2032)
6.2 North America Oncolytic Virus Manufacturing and Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Oncolytic Virus Manufacturing and Development Services Market Size by Country (2021–2026)
6.4 North America Oncolytic Virus Manufacturing and Development Services Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncolytic Virus Manufacturing and Development Services Market Size (2021–2032)
7.2 Europe Oncolytic Virus Manufacturing and Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Oncolytic Virus Manufacturing and Development Services Market Size by Country (2021–2026)
7.4 Europe Oncolytic Virus Manufacturing and Development Services Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size (2021–2032)
8.2 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size by Region (2021–2026)
8.4 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Oncolytic Virus Manufacturing and Development Services Market Size (2021–2032)
9.2 Latin America Oncolytic Virus Manufacturing and Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Oncolytic Virus Manufacturing and Development Services Market Size by Country (2021–2026)
9.4 Latin America Oncolytic Virus Manufacturing and Development Services Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size (2021–2032)
10.2 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size by Country (2021–2026)
10.4 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Recipharm (Vibalogics)
11.1.1 Recipharm (Vibalogics) Company Details
11.1.2 Recipharm (Vibalogics) Business Overview
11.1.3 Recipharm (Vibalogics) Oncolytic Virus Manufacturing and Development Services Introduction
11.1.4 Recipharm (Vibalogics) Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.1.5 Recipharm (Vibalogics) Recent Development
11.2 IDT Biologika
11.2.1 IDT Biologika Company Details
11.2.2 IDT Biologika Business Overview
11.2.3 IDT Biologika Oncolytic Virus Manufacturing and Development Services Introduction
11.2.4 IDT Biologika Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.2.5 IDT Biologika Recent Development
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Details
11.3.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.3.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing and Development Services Introduction
11.3.4 FUJIFILM Diosynth Biotechnologies Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.3.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.4 Exothera
11.4.1 Exothera Company Details
11.4.2 Exothera Business Overview
11.4.3 Exothera Oncolytic Virus Manufacturing and Development Services Introduction
11.4.4 Exothera Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.4.5 Exothera Recent Development
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza Oncolytic Virus Manufacturing and Development Services Introduction
11.5.4 Lonza Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.5.5 Lonza Recent Development
11.6 Creative Biolabs
11.6.1 Creative Biolabs Company Details
11.6.2 Creative Biolabs Business Overview
11.6.3 Creative Biolabs Oncolytic Virus Manufacturing and Development Services Introduction
11.6.4 Creative Biolabs Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.6.5 Creative Biolabs Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio Oncolytic Virus Manufacturing and Development Services Introduction
11.7.4 Takara Bio Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.7.5 Takara Bio Recent Development
11.8 Libentech
11.8.1 Libentech Company Details
11.8.2 Libentech Business Overview
11.8.3 Libentech Oncolytic Virus Manufacturing and Development Services Introduction
11.8.4 Libentech Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.8.5 Libentech Recent Development
11.9 ABL
11.9.1 ABL Company Details
11.9.2 ABL Business Overview
11.9.3 ABL Oncolytic Virus Manufacturing and Development Services Introduction
11.9.4 ABL Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.9.5 ABL Recent Development
11.10 Nabios
11.10.1 Nabios Company Details
11.10.2 Nabios Business Overview
11.10.3 Nabios Oncolytic Virus Manufacturing and Development Services Introduction
11.10.4 Nabios Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.10.5 Nabios Recent Development
11.11 Halix
11.11.1 Halix Company Details
11.11.2 Halix Business Overview
11.11.3 Halix Oncolytic Virus Manufacturing and Development Services Introduction
11.11.4 Halix Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.11.5 Halix Recent Development
11.12 Obio Technology
11.12.1 Obio Technology Company Details
11.12.2 Obio Technology Business Overview
11.12.3 Obio Technology Oncolytic Virus Manufacturing and Development Services Introduction
11.12.4 Obio Technology Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.12.5 Obio Technology Recent Development
11.13 Porton Advanced
11.13.1 Porton Advanced Company Details
11.13.2 Porton Advanced Business Overview
11.13.3 Porton Advanced Oncolytic Virus Manufacturing and Development Services Introduction
11.13.4 Porton Advanced Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.13.5 Porton Advanced Recent Development
11.14 WuXi ATU
11.14.1 WuXi ATU Company Details
11.14.2 WuXi ATU Business Overview
11.14.3 WuXi ATU Oncolytic Virus Manufacturing and Development Services Introduction
11.14.4 WuXi ATU Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.14.5 WuXi ATU Recent Development
11.15 Genevoyager
11.15.1 Genevoyager Company Details
11.15.2 Genevoyager Business Overview
11.15.3 Genevoyager Oncolytic Virus Manufacturing and Development Services Introduction
11.15.4 Genevoyager Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.15.5 Genevoyager Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Oncolytic Herpes Simplex Virus
1.2.3 Oncolytic Adenovirus
1.2.4 Oncolytic Vaccinia Virus
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oncolytic Virus Manufacturing and Development Services Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 R&D
1.3.3 Biopharmaceutical Manufacturers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Manufacturing and Development Services Market Perspective (2021–2032)
2.2 Global Oncolytic Virus Manufacturing and Development Services Growth Trends by Region
2.2.1 Global Oncolytic Virus Manufacturing and Development Services Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Oncolytic Virus Manufacturing and Development Services Historic Market Size by Region (2021–2026)
2.2.3 Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Region (2027–2032)
2.3 Oncolytic Virus Manufacturing and Development Services Market Dynamics
2.3.1 Oncolytic Virus Manufacturing and Development Services Industry Trends
2.3.2 Oncolytic Virus Manufacturing and Development Services Market Drivers
2.3.3 Oncolytic Virus Manufacturing and Development Services Market Challenges
2.3.4 Oncolytic Virus Manufacturing and Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Manufacturing and Development Services Players by Revenue
3.1.1 Global Top Oncolytic Virus Manufacturing and Development Services Players by Revenue (2021–2026)
3.1.2 Global Oncolytic Virus Manufacturing and Development Services Revenue Market Share by Players (2021–2026)
3.2 Global Top Oncolytic Virus Manufacturing and Development Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Oncolytic Virus Manufacturing and Development Services Revenue
3.4 Global Oncolytic Virus Manufacturing and Development Services Market Concentration Ratio
3.4.1 Global Oncolytic Virus Manufacturing and Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Manufacturing and Development Services Revenue in 2025
3.5 Global Key Players of Oncolytic Virus Manufacturing and Development Services Head Offices and Areas Served
3.6 Global Key Players of Oncolytic Virus Manufacturing and Development Services, Products and Applications
3.7 Global Key Players of Oncolytic Virus Manufacturing and Development Services, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Oncolytic Virus Manufacturing and Development Services Breakdown Data by Type
4.1 Global Oncolytic Virus Manufacturing and Development Services Historic Market Size by Type (2021–2026)
4.2 Global Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Type (2027–2032)
5 Oncolytic Virus Manufacturing and Development Services Breakdown Data by Application
5.1 Global Oncolytic Virus Manufacturing and Development Services Historic Market Size by Application (2021–2026)
5.2 Global Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Oncolytic Virus Manufacturing and Development Services Market Size (2021–2032)
6.2 North America Oncolytic Virus Manufacturing and Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Oncolytic Virus Manufacturing and Development Services Market Size by Country (2021–2026)
6.4 North America Oncolytic Virus Manufacturing and Development Services Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncolytic Virus Manufacturing and Development Services Market Size (2021–2032)
7.2 Europe Oncolytic Virus Manufacturing and Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Oncolytic Virus Manufacturing and Development Services Market Size by Country (2021–2026)
7.4 Europe Oncolytic Virus Manufacturing and Development Services Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size (2021–2032)
8.2 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size by Region (2021–2026)
8.4 Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Oncolytic Virus Manufacturing and Development Services Market Size (2021–2032)
9.2 Latin America Oncolytic Virus Manufacturing and Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Oncolytic Virus Manufacturing and Development Services Market Size by Country (2021–2026)
9.4 Latin America Oncolytic Virus Manufacturing and Development Services Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size (2021–2032)
10.2 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size by Country (2021–2026)
10.4 Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Recipharm (Vibalogics)
11.1.1 Recipharm (Vibalogics) Company Details
11.1.2 Recipharm (Vibalogics) Business Overview
11.1.3 Recipharm (Vibalogics) Oncolytic Virus Manufacturing and Development Services Introduction
11.1.4 Recipharm (Vibalogics) Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.1.5 Recipharm (Vibalogics) Recent Development
11.2 IDT Biologika
11.2.1 IDT Biologika Company Details
11.2.2 IDT Biologika Business Overview
11.2.3 IDT Biologika Oncolytic Virus Manufacturing and Development Services Introduction
11.2.4 IDT Biologika Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.2.5 IDT Biologika Recent Development
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Details
11.3.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.3.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing and Development Services Introduction
11.3.4 FUJIFILM Diosynth Biotechnologies Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.3.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.4 Exothera
11.4.1 Exothera Company Details
11.4.2 Exothera Business Overview
11.4.3 Exothera Oncolytic Virus Manufacturing and Development Services Introduction
11.4.4 Exothera Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.4.5 Exothera Recent Development
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza Oncolytic Virus Manufacturing and Development Services Introduction
11.5.4 Lonza Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.5.5 Lonza Recent Development
11.6 Creative Biolabs
11.6.1 Creative Biolabs Company Details
11.6.2 Creative Biolabs Business Overview
11.6.3 Creative Biolabs Oncolytic Virus Manufacturing and Development Services Introduction
11.6.4 Creative Biolabs Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.6.5 Creative Biolabs Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio Oncolytic Virus Manufacturing and Development Services Introduction
11.7.4 Takara Bio Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.7.5 Takara Bio Recent Development
11.8 Libentech
11.8.1 Libentech Company Details
11.8.2 Libentech Business Overview
11.8.3 Libentech Oncolytic Virus Manufacturing and Development Services Introduction
11.8.4 Libentech Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.8.5 Libentech Recent Development
11.9 ABL
11.9.1 ABL Company Details
11.9.2 ABL Business Overview
11.9.3 ABL Oncolytic Virus Manufacturing and Development Services Introduction
11.9.4 ABL Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.9.5 ABL Recent Development
11.10 Nabios
11.10.1 Nabios Company Details
11.10.2 Nabios Business Overview
11.10.3 Nabios Oncolytic Virus Manufacturing and Development Services Introduction
11.10.4 Nabios Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.10.5 Nabios Recent Development
11.11 Halix
11.11.1 Halix Company Details
11.11.2 Halix Business Overview
11.11.3 Halix Oncolytic Virus Manufacturing and Development Services Introduction
11.11.4 Halix Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.11.5 Halix Recent Development
11.12 Obio Technology
11.12.1 Obio Technology Company Details
11.12.2 Obio Technology Business Overview
11.12.3 Obio Technology Oncolytic Virus Manufacturing and Development Services Introduction
11.12.4 Obio Technology Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.12.5 Obio Technology Recent Development
11.13 Porton Advanced
11.13.1 Porton Advanced Company Details
11.13.2 Porton Advanced Business Overview
11.13.3 Porton Advanced Oncolytic Virus Manufacturing and Development Services Introduction
11.13.4 Porton Advanced Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.13.5 Porton Advanced Recent Development
11.14 WuXi ATU
11.14.1 WuXi ATU Company Details
11.14.2 WuXi ATU Business Overview
11.14.3 WuXi ATU Oncolytic Virus Manufacturing and Development Services Introduction
11.14.4 WuXi ATU Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.14.5 WuXi ATU Recent Development
11.15 Genevoyager
11.15.1 Genevoyager Company Details
11.15.2 Genevoyager Business Overview
11.15.3 Genevoyager Oncolytic Virus Manufacturing and Development Services Introduction
11.15.4 Genevoyager Revenue in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
11.15.5 Genevoyager Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Oncolytic Herpes Simplex Virus
Table 3. Key Players of Oncolytic Adenovirus
Table 4. Key Players of Oncolytic Vaccinia Virus
Table 5. Key Players of Others
Table 6. Global Oncolytic Virus Manufacturing and Development Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Oncolytic Virus Manufacturing and Development Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Oncolytic Virus Manufacturing and Development Services Market Size by Region (US$ Million), 2021–2026
Table 9. Global Oncolytic Virus Manufacturing and Development Services Market Share by Region (2021–2026)
Table 10. Global Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Oncolytic Virus Manufacturing and Development Services Market Share by Region (2027–2032)
Table 12. Oncolytic Virus Manufacturing and Development Services Market Trends
Table 13. Oncolytic Virus Manufacturing and Development Services Market Drivers
Table 14. Oncolytic Virus Manufacturing and Development Services Market Challenges
Table 15. Oncolytic Virus Manufacturing and Development Services Market Restraints
Table 16. Global Oncolytic Virus Manufacturing and Development Services Revenue by Players (US$ Million), 2021–2026
Table 17. Global Oncolytic Virus Manufacturing and Development Services Market Share by Players (2021–2026)
Table 18. Global Top Oncolytic Virus Manufacturing and Development Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Oncolytic Virus Manufacturing and Development Services Revenue, 2025
Table 19. Ranking of Global Top Oncolytic Virus Manufacturing and Development Services Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Oncolytic Virus Manufacturing and Development Services Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Oncolytic Virus Manufacturing and Development Services, Headquarters and Area Served
Table 22. Global Key Players of Oncolytic Virus Manufacturing and Development Services, Products and Applications
Table 23. Global Key Players of Oncolytic Virus Manufacturing and Development Services, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Oncolytic Virus Manufacturing and Development Services Market Size by Type (US$ Million), 2021–2026
Table 26. Global Oncolytic Virus Manufacturing and Development Services Revenue Market Share by Type (2021–2026)
Table 27. Global Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Oncolytic Virus Manufacturing and Development Services Revenue Market Share by Type (2027–2032)
Table 29. Global Oncolytic Virus Manufacturing and Development Services Market Size by Application (US$ Million), 2021–2026
Table 30. Global Oncolytic Virus Manufacturing and Development Services Revenue Market Share by Application (2021–2026)
Table 31. Global Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Oncolytic Virus Manufacturing and Development Services Revenue Market Share by Application (2027–2032)
Table 33. North America Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2021–2026
Table 35. North America Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2027–2032
Table 48. Recipharm (Vibalogics) Company Details
Table 49. Recipharm (Vibalogics) Business Overview
Table 50. Recipharm (Vibalogics) Oncolytic Virus Manufacturing and Development Services Product
Table 51. Recipharm (Vibalogics) Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 52. Recipharm (Vibalogics) Recent Development
Table 53. IDT Biologika Company Details
Table 54. IDT Biologika Business Overview
Table 55. IDT Biologika Oncolytic Virus Manufacturing and Development Services Product
Table 56. IDT Biologika Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 57. IDT Biologika Recent Development
Table 58. FUJIFILM Diosynth Biotechnologies Company Details
Table 59. FUJIFILM Diosynth Biotechnologies Business Overview
Table 60. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing and Development Services Product
Table 61. FUJIFILM Diosynth Biotechnologies Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 62. FUJIFILM Diosynth Biotechnologies Recent Development
Table 63. Exothera Company Details
Table 64. Exothera Business Overview
Table 65. Exothera Oncolytic Virus Manufacturing and Development Services Product
Table 66. Exothera Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 67. Exothera Recent Development
Table 68. Lonza Company Details
Table 69. Lonza Business Overview
Table 70. Lonza Oncolytic Virus Manufacturing and Development Services Product
Table 71. Lonza Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 72. Lonza Recent Development
Table 73. Creative Biolabs Company Details
Table 74. Creative Biolabs Business Overview
Table 75. Creative Biolabs Oncolytic Virus Manufacturing and Development Services Product
Table 76. Creative Biolabs Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 77. Creative Biolabs Recent Development
Table 78. Takara Bio Company Details
Table 79. Takara Bio Business Overview
Table 80. Takara Bio Oncolytic Virus Manufacturing and Development Services Product
Table 81. Takara Bio Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 82. Takara Bio Recent Development
Table 83. Libentech Company Details
Table 84. Libentech Business Overview
Table 85. Libentech Oncolytic Virus Manufacturing and Development Services Product
Table 86. Libentech Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 87. Libentech Recent Development
Table 88. ABL Company Details
Table 89. ABL Business Overview
Table 90. ABL Oncolytic Virus Manufacturing and Development Services Product
Table 91. ABL Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 92. ABL Recent Development
Table 93. Nabios Company Details
Table 94. Nabios Business Overview
Table 95. Nabios Oncolytic Virus Manufacturing and Development Services Product
Table 96. Nabios Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 97. Nabios Recent Development
Table 98. Halix Company Details
Table 99. Halix Business Overview
Table 100. Halix Oncolytic Virus Manufacturing and Development Services Product
Table 101. Halix Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 102. Halix Recent Development
Table 103. Obio Technology Company Details
Table 104. Obio Technology Business Overview
Table 105. Obio Technology Oncolytic Virus Manufacturing and Development Services Product
Table 106. Obio Technology Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 107. Obio Technology Recent Development
Table 108. Porton Advanced Company Details
Table 109. Porton Advanced Business Overview
Table 110. Porton Advanced Oncolytic Virus Manufacturing and Development Services Product
Table 111. Porton Advanced Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 112. Porton Advanced Recent Development
Table 113. WuXi ATU Company Details
Table 114. WuXi ATU Business Overview
Table 115. WuXi ATU Oncolytic Virus Manufacturing and Development Services Product
Table 116. WuXi ATU Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 117. WuXi ATU Recent Development
Table 118. Genevoyager Company Details
Table 119. Genevoyager Business Overview
Table 120. Genevoyager Oncolytic Virus Manufacturing and Development Services Product
Table 121. Genevoyager Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 122. Genevoyager Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Oncolytic Virus Manufacturing and Development Services Picture
Figure 2. Global Oncolytic Virus Manufacturing and Development Services Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Oncolytic Virus Manufacturing and Development Services Market Share by Type: 2025 vs 2032
Figure 4. Oncolytic Herpes Simplex Virus Features
Figure 5. Oncolytic Adenovirus Features
Figure 6. Oncolytic Vaccinia Virus Features
Figure 7. Others Features
Figure 8. Global Oncolytic Virus Manufacturing and Development Services Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Oncolytic Virus Manufacturing and Development Services Market Share by Application: 2025 vs 2032
Figure 10. R&D Case Studies
Figure 11. Biopharmaceutical Manufacturers Case Studies
Figure 12. Others Case Studies
Figure 13. Oncolytic Virus Manufacturing and Development Services Report Years Considered
Figure 14. Global Oncolytic Virus Manufacturing and Development Services Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Oncolytic Virus Manufacturing and Development Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Oncolytic Virus Manufacturing and Development Services Market Share by Region: 2025 vs 2032
Figure 17. Global Oncolytic Virus Manufacturing and Development Services Market Share by Players in 2025
Figure 18. Global Oncolytic Virus Manufacturing and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Oncolytic Virus Manufacturing and Development Services Revenue in 2025
Figure 20. North America Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Oncolytic Virus Manufacturing and Development Services Market Share by Country (2021–2032)
Figure 22. United States Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Oncolytic Virus Manufacturing and Development Services Market Share by Country (2021–2032)
Figure 26. Germany Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Share by Region (2021–2032)
Figure 34. China Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Oncolytic Virus Manufacturing and Development Services Market Share by Country (2021–2032)
Figure 42. Mexico Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Share by Country (2021–2032)
Figure 46. Israel Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Recipharm (Vibalogics) Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 50. IDT Biologika Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 51. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 52. Exothera Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 53. Lonza Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 54. Creative Biolabs Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 55. Takara Bio Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 56. Libentech Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 57. ABL Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 58. Nabios Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 59. Halix Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 60. Obio Technology Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 61. Porton Advanced Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 62. WuXi ATU Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 63. Genevoyager Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Oncolytic Herpes Simplex Virus
Table 3. Key Players of Oncolytic Adenovirus
Table 4. Key Players of Oncolytic Vaccinia Virus
Table 5. Key Players of Others
Table 6. Global Oncolytic Virus Manufacturing and Development Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Oncolytic Virus Manufacturing and Development Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Oncolytic Virus Manufacturing and Development Services Market Size by Region (US$ Million), 2021–2026
Table 9. Global Oncolytic Virus Manufacturing and Development Services Market Share by Region (2021–2026)
Table 10. Global Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Oncolytic Virus Manufacturing and Development Services Market Share by Region (2027–2032)
Table 12. Oncolytic Virus Manufacturing and Development Services Market Trends
Table 13. Oncolytic Virus Manufacturing and Development Services Market Drivers
Table 14. Oncolytic Virus Manufacturing and Development Services Market Challenges
Table 15. Oncolytic Virus Manufacturing and Development Services Market Restraints
Table 16. Global Oncolytic Virus Manufacturing and Development Services Revenue by Players (US$ Million), 2021–2026
Table 17. Global Oncolytic Virus Manufacturing and Development Services Market Share by Players (2021–2026)
Table 18. Global Top Oncolytic Virus Manufacturing and Development Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Oncolytic Virus Manufacturing and Development Services Revenue, 2025
Table 19. Ranking of Global Top Oncolytic Virus Manufacturing and Development Services Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Oncolytic Virus Manufacturing and Development Services Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Oncolytic Virus Manufacturing and Development Services, Headquarters and Area Served
Table 22. Global Key Players of Oncolytic Virus Manufacturing and Development Services, Products and Applications
Table 23. Global Key Players of Oncolytic Virus Manufacturing and Development Services, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Oncolytic Virus Manufacturing and Development Services Market Size by Type (US$ Million), 2021–2026
Table 26. Global Oncolytic Virus Manufacturing and Development Services Revenue Market Share by Type (2021–2026)
Table 27. Global Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Oncolytic Virus Manufacturing and Development Services Revenue Market Share by Type (2027–2032)
Table 29. Global Oncolytic Virus Manufacturing and Development Services Market Size by Application (US$ Million), 2021–2026
Table 30. Global Oncolytic Virus Manufacturing and Development Services Revenue Market Share by Application (2021–2026)
Table 31. Global Oncolytic Virus Manufacturing and Development Services Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Oncolytic Virus Manufacturing and Development Services Revenue Market Share by Application (2027–2032)
Table 33. North America Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2021–2026
Table 35. North America Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size by Country (US$ Million), 2027–2032
Table 48. Recipharm (Vibalogics) Company Details
Table 49. Recipharm (Vibalogics) Business Overview
Table 50. Recipharm (Vibalogics) Oncolytic Virus Manufacturing and Development Services Product
Table 51. Recipharm (Vibalogics) Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 52. Recipharm (Vibalogics) Recent Development
Table 53. IDT Biologika Company Details
Table 54. IDT Biologika Business Overview
Table 55. IDT Biologika Oncolytic Virus Manufacturing and Development Services Product
Table 56. IDT Biologika Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 57. IDT Biologika Recent Development
Table 58. FUJIFILM Diosynth Biotechnologies Company Details
Table 59. FUJIFILM Diosynth Biotechnologies Business Overview
Table 60. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing and Development Services Product
Table 61. FUJIFILM Diosynth Biotechnologies Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 62. FUJIFILM Diosynth Biotechnologies Recent Development
Table 63. Exothera Company Details
Table 64. Exothera Business Overview
Table 65. Exothera Oncolytic Virus Manufacturing and Development Services Product
Table 66. Exothera Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 67. Exothera Recent Development
Table 68. Lonza Company Details
Table 69. Lonza Business Overview
Table 70. Lonza Oncolytic Virus Manufacturing and Development Services Product
Table 71. Lonza Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 72. Lonza Recent Development
Table 73. Creative Biolabs Company Details
Table 74. Creative Biolabs Business Overview
Table 75. Creative Biolabs Oncolytic Virus Manufacturing and Development Services Product
Table 76. Creative Biolabs Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 77. Creative Biolabs Recent Development
Table 78. Takara Bio Company Details
Table 79. Takara Bio Business Overview
Table 80. Takara Bio Oncolytic Virus Manufacturing and Development Services Product
Table 81. Takara Bio Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 82. Takara Bio Recent Development
Table 83. Libentech Company Details
Table 84. Libentech Business Overview
Table 85. Libentech Oncolytic Virus Manufacturing and Development Services Product
Table 86. Libentech Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 87. Libentech Recent Development
Table 88. ABL Company Details
Table 89. ABL Business Overview
Table 90. ABL Oncolytic Virus Manufacturing and Development Services Product
Table 91. ABL Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 92. ABL Recent Development
Table 93. Nabios Company Details
Table 94. Nabios Business Overview
Table 95. Nabios Oncolytic Virus Manufacturing and Development Services Product
Table 96. Nabios Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 97. Nabios Recent Development
Table 98. Halix Company Details
Table 99. Halix Business Overview
Table 100. Halix Oncolytic Virus Manufacturing and Development Services Product
Table 101. Halix Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 102. Halix Recent Development
Table 103. Obio Technology Company Details
Table 104. Obio Technology Business Overview
Table 105. Obio Technology Oncolytic Virus Manufacturing and Development Services Product
Table 106. Obio Technology Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 107. Obio Technology Recent Development
Table 108. Porton Advanced Company Details
Table 109. Porton Advanced Business Overview
Table 110. Porton Advanced Oncolytic Virus Manufacturing and Development Services Product
Table 111. Porton Advanced Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 112. Porton Advanced Recent Development
Table 113. WuXi ATU Company Details
Table 114. WuXi ATU Business Overview
Table 115. WuXi ATU Oncolytic Virus Manufacturing and Development Services Product
Table 116. WuXi ATU Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 117. WuXi ATU Recent Development
Table 118. Genevoyager Company Details
Table 119. Genevoyager Business Overview
Table 120. Genevoyager Oncolytic Virus Manufacturing and Development Services Product
Table 121. Genevoyager Revenue in Oncolytic Virus Manufacturing and Development Services Business (US$ Million), 2021–2026
Table 122. Genevoyager Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Oncolytic Virus Manufacturing and Development Services Picture
Figure 2. Global Oncolytic Virus Manufacturing and Development Services Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Oncolytic Virus Manufacturing and Development Services Market Share by Type: 2025 vs 2032
Figure 4. Oncolytic Herpes Simplex Virus Features
Figure 5. Oncolytic Adenovirus Features
Figure 6. Oncolytic Vaccinia Virus Features
Figure 7. Others Features
Figure 8. Global Oncolytic Virus Manufacturing and Development Services Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Oncolytic Virus Manufacturing and Development Services Market Share by Application: 2025 vs 2032
Figure 10. R&D Case Studies
Figure 11. Biopharmaceutical Manufacturers Case Studies
Figure 12. Others Case Studies
Figure 13. Oncolytic Virus Manufacturing and Development Services Report Years Considered
Figure 14. Global Oncolytic Virus Manufacturing and Development Services Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Oncolytic Virus Manufacturing and Development Services Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Oncolytic Virus Manufacturing and Development Services Market Share by Region: 2025 vs 2032
Figure 17. Global Oncolytic Virus Manufacturing and Development Services Market Share by Players in 2025
Figure 18. Global Oncolytic Virus Manufacturing and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Oncolytic Virus Manufacturing and Development Services Revenue in 2025
Figure 20. North America Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Oncolytic Virus Manufacturing and Development Services Market Share by Country (2021–2032)
Figure 22. United States Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Oncolytic Virus Manufacturing and Development Services Market Share by Country (2021–2032)
Figure 26. Germany Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Oncolytic Virus Manufacturing and Development Services Market Share by Region (2021–2032)
Figure 34. China Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Oncolytic Virus Manufacturing and Development Services Market Share by Country (2021–2032)
Figure 42. Mexico Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Oncolytic Virus Manufacturing and Development Services Market Share by Country (2021–2032)
Figure 46. Israel Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Oncolytic Virus Manufacturing and Development Services Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Recipharm (Vibalogics) Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 50. IDT Biologika Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 51. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 52. Exothera Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 53. Lonza Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 54. Creative Biolabs Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 55. Takara Bio Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 56. Libentech Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 57. ABL Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 58. Nabios Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 59. Halix Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 60. Obio Technology Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 61. Porton Advanced Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 62. WuXi ATU Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 63. Genevoyager Revenue Growth Rate in Oncolytic Virus Manufacturing and Development Services Business (2021–2026)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232